SCHEMBL6171937

SCHEMBL6171937

CN1CCC(c2cc(C(NC=O)N3C(=O)N(c4ccc(S(=O)(=O)C(F)(F)F)cc4)C(=O)C3(C)C)ccn2)CC1

nearest known ligand 0.41

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 14/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173312 0.83 IGF1R (0.34) IGF1R
SCHEMBL6171670 0.82 IGF1R (0.38) IGF1R
SCHEMBL6173915 0.75 IGF1R (0.41) IGF1R
SCHEMBL6175147 0.74 HTR2A (0.34)
SCHEMBL2942754 0.71 IGF1R (0.57) IGF1R
SCHEMBL6173685 0.70 HTR6 (0.33) IGF1R
SCHEMBL2940341 0.70 IGF1R (0.40) IGF1R
SCHEMBL2939198 0.69 IGF1R (0.43) IGF1R
SCHEMBL6175215 0.68 CTSS (0.34) IGF1R
SCHEMBL6172419 0.68 HRH4 (0.38) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed